A systematic review of the literature about patients' preferences for involvement in cancer treatment decision making was conducted. Establishing preferences is important if the aim is to make health care more sensitive to the needs and expectations of each individual patient. Thirty-one papers were included in the review. Generalising from this literature is problematic because of limitations related to sample size, sample composition and methods used to assess preferences. Whilst we take cognizance of these limitations, research suggests that preferences vary considerably and that whilst most patients prefer a collaborative role, a significant minority prefer a passive or active role. Evidence about the association of factors such as age, gender, level of education, marital status, socioeconomic status and health status with preferences is inconclusive. Only a handful of studies investigated the degree of congruence between patients' role preferences and the actual role that they perceived they had played, which highlight that some patients experience a dissonance between the two. Similarly, few studies investigated the impact of this dissonance on patient anxiety or satisfaction with the treatment decision. We advocate more rigorous investigations before recommendations for health care professionals can be processed with confidence.
Introduction
Health and social care policy promotes the agenda of involvement by encouraging patients, careers and members of the public to adopt a greater level of responsibility for and participation in health care, including, playing a much greater role in decisions affecting their own treatment and care (Department of Health, 2003) . Medical ethics has emphasised the right of patients to be fully informed and to participate in treatment decision making, which is legislated for in some countries (Guadagnoli and Ward, 1998) . The recent emphasis on patient involvement and autonomy in health care settings is indicative of efforts to promote a move away from a paternalistic form of care towards one of partnership between the medical profession and patients. This, in turn, reflects wider cultural tendencies that position patients as active consumers and citizens involved in making health care decisions.
There is a wealth of evidence related to treatment decision making for patients with cancer. This includes a significant amount of research about the use of decision aids (Caress, 2000) to facilitate decision making, but also a small but growing amount of literature related to other aspects of treatment decision making including research about the influence of patient involvement in treatment decision making on quality of life (Andersen and Urban, 1999) , the impact of the media on treatment decision making (Passalacqu et al., 2004) , the relationship of depression and anxiety to treatment decision making (Petersen et al., 2003) , how married couples interact in reaching a treatment decision (Boehmer and Clark, 2001 ), patients' attitudes towards different treatment options (Brundage et al., 2001) , decisional regret (Davison and Goldenberg, 2003) , decision making in palliative care treatment (De Haes and Koedoot, 2003) and preferences for different types of treatment (Soloman et al., 2003) .
Researchers have also investigated patients' preferences for involvement in treatment decision making. Establishing preferences for involvement in treatment decision making is important if the aim is to make health care more sensitive to the needs and expectations of each individual patient. Since patients are not a homogenous group, it cannot be assumed that they will all want to play an active or collaborative role in making decisions about their care. Thus, a shared decision-making process with doctors and patients involved in treatment decision making may be too simplistic of a model. This is why the process of health care professionals systematically finding out about patient preferences in relation to involvement in treatment decision making is seen as crucial.
As part of a larger systematic review of literature about the agenda of involvement in cancer care, a review of research about patients' preferences for involvement in treatment decision making was conducted (Hubbard et al., 2007) . The review aimed to improve understanding of the role that patients with cancer want in relation to their treatment decision making, sociodemographic factors that influence role preference, the degree of congruence between patients' preferred and actual roles in treatment decision making, and the impact of role preferences on outcomes, such as patient satisfaction.
Methods

Type of review
This review was carried out using systematic methods to produce a narrative summary. We used systematic methods to search for literature, applied inclusion and exclusion criteria, appraised the quality of studies included, selected relevant data from the included studies for analysis and provided a narrative summary of these data.
Searching for literature
All database searches ran from 1994 to 2004 inclusive. No language, geographical or methodological limits, was imposed on the results. The majority of hits were contained within the major and best-known health databases: AMED (Allied and Complementary Medicine), CINAHL, EMBASE, Evidence Based Medicine Reviews (Cochrane DSR, ACP Journal Club, DARE and CCTR), HMIC (Health Management Information Consortium), Medline and PsychINFO. A broad search including subject headings of the terms 'decision' (for example, decision making, choice, decision and decisional) and 'cancer' (for example, oncology, neoplasm and tumour) was employed. A cited reference search and free test searches were also conducted.
Inclusion and exclusion of documents
The 279 papers were examined for potential inclusion in the review. Two members of the review team read abstracts and decided which papers to include in the review. Only research studies or reviews of literature about preferences for involvement in treatment decision making for cancer were included. Papers were included even if preferences for involvement in treatment decision making were only a part of the study. For example, if the study was also about preferences for information but contained findings on preferences for involvement in treatment decision making, it was included. Papers about role preferences for decision making about screening for cancer or genetic testing were not included because the focus of the review was on decisions related to treatment. Papers were included if the sample also included other groups of the population, such as patients with different diseases in addition to patients with a diagnosis of cancer, or groups of people that were related to patients with cancer for example, parents. There is a vast amount of literature about treatment decision making and the majority of papers excluded from the review were those that were about decision-making aids.
Quality appraisal
Quality appraisal was conducted for all documents using the same criteria developed by Dixon Woods et al. (2005) , as shown in Box 1. Their criterion judges a paper on the clarity and explication of the aims and objectives of the study, study design, methods and findings. Documents were rated 5 if all aspects of the study were clear, 4 if the method or analysis or sample were not clearly outlined or 3 if both the method or analysis and sample were poorly described.
Data analysis
One member of the review team extracted narrative data from each paper. Only narrative data related to preferences for involvement in treatment decision making, the factors that influence these preferences, the impact of preferences for involvement in treatment decision making on patient outcomes and the degree of congruence between patients' preferred and perceived actual role was extracted. Extracted narrative data were compared across each of the papers to identify key issues and summarise key points. Another member of the team read the papers to confirm that relevant narrative data had been extracted.
Results
A total of 31 papers were included (26 from electronic database searches and 5 from cited references or journal searches), all of which received the highest quality appraisal rating. No literature reviews were found, thus all papers included in the review are research studies. Table 1 summarises the method employed, sample chosen and the key findings for each paper.
Methods and sample
The 31 papers were compared by method and sample. The overwhelming majority of papers (24 in total) reported using This scale categorises patients into one of three roles depending on the extent of their preferred involvement in treatment decision making:
• Active, where the patient themselves decides on which would be the most appropriate treatment option for themselves. • Collaborative (sometimes described as shared), where the patient and the doctor jointly decide on the most appropriate treatment option and • Passive, where the patient leaves the decision on themost appropriate treatment option to the doctor.
Most studies only included small numbers of patients and it was not possible from reading the paper to deduce whether or not these were representative of a larger population. Only nine studies recruited a patient group of 150 or more (Beisecker et al., 1994; Beaver et al., 1996; Degner et al., 1997; Petrisek et al., 1997; Wallberg et al., 2000; Gattellari et al., 2001; Keating et al., 2002; Beaver et al., 2003; Kraetschmer et al., 2004) . The overwhelming majority of studies included adults and focused on adult preferences for involvement in treatment decision making.
One study elicited the preferences of teenagers and young adults (Dunsmore and Quine, 1995) , one study focussed on the preferences of paediatric oncology patients (Gagnon and Recklitis, 2003) and one study focussed on the preferences of parents of paediatric oncology patients (Pyke Grimm et al., 1999) .
Samples varied considerably by cancer type (Table 2 ). Most studies focussed exclusively on women with breast cancer (12 in total) (Beisecker et al., 1994; Hack et al., 1994; Beaver et al., 1996; Bilodeau and Degner, 1996; Johnson et al., 1996; Degner et al., 1997; Petrisek et al., 1997; Wallberg et al., 2000; Lobb et al., 2001; Bruera et al., 2002; Keating et al., 2002; Janz et al., 2004) . One of these studies did not actually focus on a sample of patients with cancer but on the perceptions of oncologists, oncology nurses and patients attending a women's clinic (Beisecker et al., 1994) . Most other studies focussed on a heterogeneous patient group with a mix of different cancers (11 in total) (Dunsmore and Quine, 1995; Barry and Henderson, 1996; Butow et al., 1997; Rothenbacher et al., 1997; Stigglebout and Kiebert, 1997; Pyke Grimm et al., 1999; Bruera et al., 2001; Gattellari et al., 2001; Gagnon and Recklitis, 2003; Heyland et al., 2003; Kraetschmer et al., 2004) . One of these studies focussed on the parents of paediatric oncology patients with heterogeneous cancers . Four studies focussed on patients with prostate cancer Wong et al., 2000; Davisonet al.,2002; Davison et al., 2004) with one study focussingonpatientswithprostatecancerpre-diagnosis . Two studies focussed on patients with colorectal cancer (Beaver et al., , 2003 , whilst one study focussed on patients with lung cancer (Davidson et al., 1999) .
Study samples varied by time since diagnosis (Table 3) . Nine studies included patients who had been newly diagnosed or were in the first six months post-diagnosis Beaver et al., 1996; Bilodeau and Degner, 1996; Johnson et al., 1996; Lobb et al., 2001; Bruera et al., 2002; Davison et al., 2002; Keating et al., 2002; Janz et al., 2004) , five studies included patients who were reaching 1-2 years post-diagnosis (Petrisek et al., 1997; Pyke Grimm et al., 1999; Wallberg et al., 2000; Gattellari et al., 2001; Gagnon and Recklitis, 2003) and four studies investigated the preferences of palliative patients Rothenbacher et al., 1997; Bruera et al., 2001; Heyland et al., 2003) . It was difficult to identify the time since diagnosis in 13 of the remaining studies since the sample either comprised a mix of different stages of cancer (Dunsmore and Quine, 1995; Beaver et al., 1996; Degner et al., 1997; Beaver et al., 1999; Wong et al., 2000; Beaver et al., 2003) or were unclear Stigglebout and Kiebert, 1997; Davidson et al., 1999; Davison et al., 2002; Kraetschmer et al., 2004) . The time since diagnosis was not relevant in two studies (Beisecker et al., 1994; Davison et al., 2004) .
Preferences for involvement in treatment decision making
A total of 20 studies used Degner and Sloan (1992) (Box 2) preferences scale to categorise patients' preferences for adopting an active, passive or collaborative role in treatment decision making. In 11 of these studies, involving a range of patients with different cancer types and at different stages following diagnosis (including children and patients in the palliative stages of care), the majority of patients clearly expressed a preference for a collaborative role in treatment decision making Degner et al., 1997; Rothenbacher et al., 1997; Wallberg et al., 2000; Bruera et al., 2001; Gattellari et al., 2001; Bruera et al., 2002; Gagnon and Recklitis, 2003; Heyland et al., 2003; Davison et al., 2004; Janz et al., 2004) . In six studies, the majority of patients expressed a preference for a passive role (Bilodeau and Degner, 1996; Butow et al., 1997; Beaver et al., 1999; Davidson et al., 1999; Pyke Grimm et al., 1999; Hinds et al., 2000) . These studies involved patients with a diagnosis of breast, lung, colorectal or prostate cancer at different stages following diagnosis. Beaver et al. (1996 Beaver et al. ( , 1999 identified that although both patients with breast or colorectal cancers in these studies expressed a predominant preference for a passive role, more patients in the colorectal cancer group were likely to prefer a passive role than those in the breast cancer patient group. In a later study amongst patients with colorectal cancer only (n =375); however, Beaver et al. (2003) identified that a greater number of patients expressed a preference for a collaborative role in treatment decision making. One study of parents of paediatric oncology patients found that the majority of parents preferred a collaborative role . There were only three studies in which the majority of patients expressed a preference for an active role in treatment decision making Stigglebout and Kiebert, 1997; Davison et al., 2002) .
Factors affecting patients' preferences for involvement
A number of studies have researched the associations between patients' preferences for involvement in treatment decision making and age (16 in total) (Beisecker et al., 1994; Hack et al., 1994; Davison et al., 1995; Beaver et al., 1996; Bilodeau and Degner, 1996; Butow et al., 1997; Degner et al., 1997; Petrisek et al., 1997; Rothenbacher et al., 1997; Pyke Grimm et al., 1999; Wong et al., 2000; Lobb et al., 2001; Bruera et al., 2002; Beaver et al., 2003; Heyland et al., 2003; Davison et al., 2004) , gender (4 in total) Rothenbacher et al., 1997; Pyke Grimm et al., 1999; Beaver et al., 2003) , race/ethnicity (2 in total) Bruera et al., 2002) , level of education (15 in total) Beaver et al., 1996; Davison et al., 1995; Degner et al., 1997; Rothenbacher et al., 1997; Stigglebout and Kiebert, 1997; Pyke Grimm et al., 1999; Lobb et al., 2001; Wallberg et al., 2000; Wong et al., 2000; Bruera et al., 2002; Gagnon and Recklitis, 2003; Heyland et al., 2003; Davison et al., 2004; Janz et al., 2004) , marital status (12 in total) Butow et al., 1997; Degner et al., 1997; Rothenbacher et al., 1997; Beaver et al., 1999; Pyke Grimm et al., 1999; Wallberg et al., 2000; Lobb et al., 2001; Bruera et al., 2002; Heyland et al., 2003; Davison et al., 2004; Janz et al., 2004) , employment status (5 in total) Lobb et al., 2001; Bruera et al., 2002; Heyland et al., 2003; Janz et al., 2004) , socioeconomic status (2 in total) (Beaver et al., , 2003 , level of income (3 in total) Gagnon and Recklitis, 2003; Janz et al., 2004) , type or stage of cancer (3 in total) Wong et al., 2000; Bruera et al., 2002) and patients' health status (5 in total) Butow et al., 1997; Hinds et al., 2000; Wong et al., 2000; Bruera et al., 2002) . These findings are summarised in Table 1. Briefly, 11 studies did not identify an association between age and role preferences (Beisecker et al., 1994; Hack et al., 1994; Davison et al., 1995; Butow et al., 1997; Pyke Grimm et al., 1999; Wong et al., 2000; Bruera et al., 2002; Beaver et al., 2003; Heyland et al., 2003; Davison et al., 2004; Janz et al., 2004) . Five studies, however, including three studies involving patients with breast cancer and one study involving patients receiving palliative care, reported that younger people were more likely to prefer a collaborative or active role in decision making Bilodeau and Degner, 1996; Degner et al., 1997; Rothenbacher et al., 1997; Lobb et al., 2001) . In contrast, one study including 76 women with breast cancer reported that younger women were more likely to want their doctors to make a recommendation (Johnson et al., 1996) . Three studies reported no association between gender and role preference Rothenbacher et al., 1997; Pyke Grimm et al., 1999) , whereas one study found that women were more likely to prefer an active role (Beaver et al., 2003) . There were no studies which identified an association between race/ethnicity and role preference Bruera et al., 2002) and between level of income and role preference Gagnon and Recklitis, 2003; Janz et al., 2004) . One study reported an association between employment status and role preference, with employed patients wishing a more active role in their treatment decision making . A total of six studies, primarily involving patients diagnosed with breast cancer, have reported an association between level of education and role preference, finding that those with a higher level of education prefer a collaborative or active role in their treatment decision making Beaver et al., 1996; Degner et al., 1997; Rothenbacher et al., 1997; Wallberg et al., 2000; Janz et al., 2004) . On the other hand, eight studies have reported no such association between education and role preference Wong et al., 2000; Bruera et al., 2002; Stigglebout and Kiebert, 1997; Keating et al., 2002; Gagnon and Recklitis, 2003; Heyland et al., 2003; Davison et al., 2004) .
Marital status was found to be associated with role preference in eight studies, with married people being more likely to prefer an active role in their treatment decision making Butow et al., 1997; Rothenbacher et al., 1997; Wong et al., 2000; Lobb et al., 2001; Bruera et al., 2002; Heyland et al., 2003; Janz et al., 2004) . These studies included a range of patients with different cancer types, such as breast and prostate cancer, and at different stages in their cancer journey, including those newly diagnosed, to those in the palliative stages of their disease. Four studies, including one involving more than 1000 women with breast cancer did not identify an association between martial status and role preference Pyke Grimm et al., 1999; Davison et al., 2004) . Two studies, in patients with breast or colorectal cancers, investigated the association between socioeconomic status and role preference (Beaver et al., 1996 (Beaver et al., , 2003 . Whilst the study in patients with breast cancer (Beaver et al., 1996) identified that lower socioeconomic status was associated with a passive role, there was no such association found amongst patients with colorectal cancer (Beaver et al., 2003) .
Three studies investigated the association between patients' type or stage of cancer and role preference, but found no association Wong et al., 2000; Bruera et al., 2002) . Three studies noted an association between declining health status or the experience of cancerrelated side effects and role preference Butow et al., 1997; Hinds et al., 2000) . One study found that patients whose condition had recently worsened were more likely to want progressively less involvement in decision making, whilst another small-scale study (n =7) found that patients whose conditioned had worsened were more likely to prefer an active role in decision making. A team of researchers (Hinds et al., 2000) who investigated the preferences of patients in the palliative stages of their disease reported that nausea and the effect of fatigue on the ability of the patient to recall events, were significantly related to role preference, with more patients preferring a passive role. Two studies reported no association between health status and role preference Bruera et al., 2002) .
Degree of congruence between role preference
A total of eight studies investigated the degree of congruence between patients' role preferences and the actual role that they perceived they had played in treatment-decision making (Table 4) . These studies mainly focussed on patients with breast cancer (Bilodeau and Degner, 1996; Degner et al., 1997; Beaver et al., 1999; Wallberg et al., 2000; Keating et al., 2002) although one of these studies also incorporated patients with colorectal cancer . Two studies focussed on patients with one of a range of cancer types Gattellari et al., 2001 ) and one study focussed on patients with lung cancer . The findings from these studies revealed that there were no studies in which all patients who participated attained their role preference. In fact, in four of these studies, less than 50% of patients who participated attained their role preference Beaver et al., 1999; Gattellari et al., 2001; Keating et al., 2002) . However, researchers in one study reported that 60% of the patients who had been diagnosed with colorectal cancer attained their role preference (12% more than in the breast cancer patient group in the same study) and a total of 72% of patients with breast cancer in another study perceived that they played the role that they preferred. Three studies Bilodeau and Degner, 1996; Degner et al., 1997) investigated which patients were most likely to achieve their role preferences. One team of researchers identified that those women who had perceived that they had achieved their role preference were those who had preferred a passive role, whereas in another study (Bilodeau and Degner, 1996) , the researchers found that agreement was most evident between women who preferred an active role and who perceived that they had indeed achieved this role. A small scale pilot study of palliative patients (n =7) found that discrepancies between role preferences and role attainment increased with the progress of the disease with patients perceiving that they had played a less active role than preferred.
Four studies also investigated the degrees of congruence between patients' own role preferences and their physicians of these preferences Pyke Grimm et al., 1999; Bruera et al., 2001; Heyland et al., 2003) . In all of these studies, agreement between patients and physicians, with respect to decision-making preferences, occurred in less than 50% of cases Pyke Grimm et al., 1999; Bruera et al., 2001; Heyland et al., 2003) . One team of researchers also identified that the degree of congruence between patients' and physicians' perceptions differed between categories of income and age, with patients of a higher income status and patients who were younger being closer to physicians perceptions of their patients' decision-making preferences.
Impact of role preferences on patient outcomes
Three studies investigated whether the extent to which patients actually achieved their role preference in treatment decision making impacted upon patient outcomes, such as level of anxiety experienced and satisfaction with the consultation (Heyland et al., 2000; Keating et al., 2002; Janz et al., 2004) . One team of researchers (Heyland et al., 2000) found that patients who attained their role preference (34%) experienced significant decreases in anxiety from pre-consultation to immediate post-consultation, when compared with those whose involvement was less than anticipated. They also identified that patients who attained their role preference were more likely to be satisfied with the consultation and patients who were less active than desired were more likely to be less satisfied (Heyland et al., 2000) . Researchers , in a study involving over 1000 women with breast cancer, also reported that patients who attained their role preference (49%) were more likely to be satisfied with the treatment decision-making process. Another study , however, found that role preference in women with breast cancer (n =101) was not associated with greater levels of satisfaction with the treatment decision itself, but women who perceived that they had played a more active role in decision making were more likely to feel higher levels of satisfaction in general.
Discussion
Methodological concerns
Despite the growing abundance of research in relation to preferences for involvement in treatment decision making amongst patients with cancer, there are a number of methodological limitations of this body of work worth noting. In particular, generalising from the 31 studies included in this review is problematic because of small sample sizes, the inability to decipher from reading these papers whether or not the sample is representative of a wider population and the wide variation in the characteristics of the study samples.
Sample sizes were small in the majority of studies included in this review (only nine studies had recruited a patient group of 150 or more). This is a cause of concern for those studies that used statistical techniques to investigate relationships and correlations between variables (for example, preference for involvement in treatment decision making with age), since samples of less than 100 can produce misleading results. It is also impossible to assess from what was written in some papers about sampling and recruitment whether or not those patients sampled were representative of a larger group of the population. Yet, without this information it is not possible to assess whether findings can be generalised beyond the study sample. Moreover, most studies have either focussed on the preferences of women with breast cancer or have included a heterogeneous group of a mix of cancer types. The findings from studies focussing on patients with breast cancer, therefore, represent only a small subset of patients with cancer, whilst the inclusion of heterogeneous groups makes it impossible to determine how cancer type, stage of cancer, and indeed, treatment options, influence patients' preferences for involvement in treatment decision making. Furthermore, little research has investigated the extent to which patients' preferences vary by prognosis and severity of illness. These factors are often not considered as part of a systematic sampling strategy and hence, generalising the findings from a study of preferences for one group of patients with a specific type of cancer to another group of patients is inappropriate. Finally, largely missing from this body of research is investigations of preferences of palliative patients and those of teenagers and young people.
Another reason why caution must be used in generalising from this body of evidence is because some studies examined patients' perceptions of preferences for involvement in treatment decision making based on their recollections of the decision process. This may have been several months after the actual event, whereas other studies asked patients to recall their preferences much closer to the decision-making event. Other studies did not ask patients to recall, but rather used hypothetical examples. Although studies have varied in their sampling strategies, with some recruiting newly diagnosed patients, and others recruiting patients who may be considered in the survivorship period, or indeed in the palliative stages of their disease, it is not known the extent to which patients' perceptions of their preferences for involvement is dependent on when they are asked to recall their preferences.
The predominant method for assessing patients' preferences for involvement in treatment decision making has largely involved the use of a preferences scale (Box 2). The reliability and validity of these scales is questionable, however, since a study by Entwistle (2001) found that it is difficult for patients to select an appropriate role description using such a scale. Furthermore, patients may choose conflicting role descriptions from the scale and patients may choose descriptions which may not necessarily correspond with their narrative descriptions about how their treatment decisions were made (Entwistle, 2001 ). Concern about a lack of consensus amongst patients and health care professionals about what the concepts of participation and involvement actually mean further compounds the problem with the reliability and validity of these scales. Subsequently, further research should investigate these points in conjunction with the use of these types of scales.
Summary and gaps in evidence
Although cross comparison of published studies about patients' preferences for involvement in treatment decision making is problematic due to the limitations discussed above, the 31 studies included in this review show that patients' preferences vary quite considerably. While most patients are likely to prefer a collaborative role, a significant minority prefer a passive role, followed by those who prefer an active role. Some studies have found that this minority can be quite substantial suggesting that making assumptions that patients wish to assume responsibility for treatment decision making is not necessarily wise.
Some studies have investigated the association between factors such as, age, gender, race/ethnicity, education, level of income, marital status, employment status, socioeconomic status, type and stage of cancer and patients' health status with role preferences in treatment decision making. However, the evidence to date is contradictory, meaning that the extent to which these factors influence patients' preferences for involvement is unclear. Given the inconclusiveness of this evidence, it is not possible to predict which patients will prefer passive, active or collaborative roles in treatment decision making. Perhaps it is not surprising therefore, that physicians are not able to accurately predict patients' preferences in most cases and there is no simple formula that they can use to facilitate accurate prediction of these. It seems, on balance, that predicting patients' preferences may, therefore, be a wasted effort.
Only a handful of studies have investigated the degree of congruence between patients' role preferences and the actual role that they perceived themselves to have played in treatment decision making. This body of research suggests that whilst some patients do attain their role preference, there are many others who do not. Why some attain their role preference and others do not, however, has not been considered in any great detail. Furthermore, given the small numbers of studies that have investigated the impact of role preferences on outcomes such as, anxiety and patient satisfaction, it is not possible to confirm with certainty whether attaining role preferences, particularly active or passive roles, actually impacts on patients' outcomes. It seems naive to assume therefore, that all patients will benefit from active involvement in treatment decision making.
None of the studies included in this review examined patients' preferences for involvement in treatment decision making over time. Yet, patients' preferences may not be a static or one-off event but instead, may be a dynamic and longitudinal process for the following reasons; patients may prefer to adopt a passive role within the first few months following diagnosis, but prefer a more active role during the course of their illness or vice versa, preferences may change in relation to the stage of their disease and the seriousness of their condition, and preferences may vary according to the specific treatment decision that patients are required to consider. Whether and how preferences change over the patient journey warrants further research.
Limitations of the review
Whilst we are confident that the electronic searches identified relevant studies we did not give enough time to hand searching in all relevant journals, which means that some relevant papers may have been overlooked. Moreover, this review does not represent the complete body of research since we only included papers published between 1994 and 2004 and there has been some seminal research about preferences for involvement in treatment decision making carried out prior to 1994 (Cassileth et al., 1980; Degner and Sloan, 1992) . Finally, whereas this is a narrative review of the evidence, which is a descriptive account of the data about preferences for involvement in treatment decision making, a meta-analysis of some of the studies included here, particularly those that have similar samples and which use the same preferences scale, could also provide some useful insight about patients' preferences.
Conclusions
Changes in societal attitudes towards patient involvement in treatment decision making coupled with a much more consumerist and citizenship approach to health care is likely to affect medical practice. Those recommending increasing involvement of patients in treatment decision making have asserted that most patients prefer a collaborative role and that this leads to improved satisfaction with the consultation and decision-making process. Yet, this assertion is not confirmed by most of the empirical work conducted thus far. Evidence about patients' preferred level of involvement in treatment decision making, the factors that influence their level of involvement, the degree of congruence between their preferred and actual roles in treatment decision making and the impact of their involvement on patient outcomes is not compelling. More rigorous investigations are required before recommendations for health care professionals can be processed with full confidence. It is with this proviso in mind that we conclude by making the following recommendations for health professionals in relation to patients' involvement in treatment decision making which stand in the face of the limited current evidence base.
Given that patients vary in their preferences for involvement in treatment decision making, it is important that health care professionals identify individual decision-making preferences, rather than advocate participation or non-participation for all patients. To deliver patient-centred care that privileges the needs of the patient above those of the system, health professionals should assess each patient individually and acknowledge that preferences are likely to change over time and with the influence of many factors. Thus, assessing preferences for involvement is not a onetime event but rather, a process that should be conducted throughout the duration of the patients' cancer journey. Finally, there is no formula for predicting patients' preferences and so possibly, the easiest way to find out about patients' preferences for involvement in treatment decision making is simply by asking them.
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